V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003031 | 330001613 | 1.68 | 76 | Disease modification (D) | 2015-08-06 | 2017-01-27 | BENDAMUSTINE + RITUXIMAB | N | N | 330012016 | BENDAMUSTINE + RITUXIMAB |
| 330003032 | 330001613 | 1.54 | 44.2 | Palliative (P) | null | 2014-03-07 | Doxorubicin 75mg/m2 | N | N | 330012016 | DOXORUBICIN |
| 330003033 | 330012640 | 1.7 | 68.5 | Palliative (P) | 2015-11-19 | 2015-11-29 | DOXORUBICIN | 02 | N | 330012032 | DOXORUBICIN |
| 330003034 | 330012640 | 1.81 | 55.8 | null | 2013-03-12 | 2013-03-13 | Cisplatin + Doxorubicin | 02 | N | 330012032 | CISPLATIN + DOXORUBICIN |
| 330003035 | 330012640 | 1.76 | 83.9 | Curative (C) | 2014-03-26 | 2014-04-22 | Doxorubicin 75mg/m2 | N | N | 330012032 | DOXORUBICIN |
| 330003036 | 330012640 | 1.63 | 84 | Palliative (P) | 2016-12-02 | 2016-12-24 | DOXORUBICIN | N | N | 330012032 | DOXORUBICIN |
| 330003037 | 330001614 | 1.69 | 82.1 | Palliative (P) | null | 2018-05-23 | Liposomal Doxorubicin (Caelyx) | null | null | 330012038 | LIPOSOMAL DOXORUBICIN |
| 330003038 | 330001615 | 1.57 | 77.9 | Neo-adjuvant (N) | null | 2017-02-10 | Cisplatin + Doxorubicin | N | N | 330012041 | CISPLATIN + DOXORUBICIN |
| 330003039 | 330001615 | 1.61 | null | Adjuvant (A) | 2017-10-12 | 2017-10-15 | CNS GCT II Germinoma - Carbo Etop | N | Y | 330012041 | CARBOPLATIN + ETOPOSIDE |
| 330003040 | 330001616 | 1.88 | 93.3 | Palliative (P) | 2013-08-13 | 2013-08-20 | DOXORUBICIN | N | N | 330012047 | DOXORUBICIN |
| 330003041 | 330001617 | null | 78 | Not known (9) | 2013-03-28 | 2013-04-02 | Liposomal Doxorubicin (20mg/m2) | N | N | 330012051 | LIPOSOMAL DOXORUBICIN |
| 330003042 | 330001618 | 1.76 | 77.5 | Disease modification (D) | 2016-01-24 | 2016-01-24 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330012054 | BENDAMUSTINE + RITUXIMAB |
| 330003043 | 330001619 | 1.82 | 63 | Palliative (P) | 2016-10-14 | 2016-10-21 | DOXORUBICIN | N | N | 330012055 | DOXORUBICIN |
| 330003044 | 330006860 | null | 96 | null | 2015-11-04 | 2015-11-04 | Doxorubicin 75mg/m2 | null | null | 330012056 | DOXORUBICIN |
| 330003045 | 330006860 | 1.8 | 66 | Palliative (P) | null | 2016-05-09 | CARBOPLATIN + PACLITAXEL | null | null | 330012056 | CARBOPLATIN + PACLITAXEL |
| 330003051 | 330001622 | 1.48 | 77.4 | Palliative (P) | 2016-11-11 | 2016-11-12 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012071 | CARBOPLATIN + PACLITAXEL |
| 330003052 | 330001623 | 0 | 43.8 | Neo-adjuvant (N) | 2015-04-10 | 2015-04-12 | Cisplatin + Doxorubicin | 02 | N | 330012072 | CISPLATIN + DOXORUBICIN |
| 330003053 | 330001623 | 1.6 | 100 | Disease modification (D) | 2015-06-20 | 2015-07-09 | BENDAMUSTINE + RITUXIMAB | N | N | 330012072 | BENDAMUSTINE + RITUXIMAB |
| 330003054 | 330001623 | 0 | 91 | Disease modification (D) | 2017-11-09 | 2017-11-24 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330012072 | BENDAMUSTINE + RITUXIMAB |
| 330003055 | 330001623 | 1.62 | 63.5 | Palliative (P) | 2016-11-22 | 2016-11-22 | Carboplatin + Etoposide IV 3 day | 02 | N | 330012072 | CARBOPLATIN + ETOPOSIDE |
| 330003056 | 330001624 | 1.52 | 68 | Disease modification (D) | null | 2013-11-14 | Rituximab | null | null | 330012078 | RITUXIMAB |
| 330003057 | 330001625 | 1.5 | 61.9 | Curative (C) | null | 2013-08-22 | CARBOPLATIN | null | null | 330012080 | CARBOPLATIN |
| 330003060 | 330001627 | 1.7 | 70.9 | Unknown (U) | 2015-10-25 | 2015-10-25 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330012089 | BENDAMUSTINE + RITUXIMAB |
| 330003061 | 330001627 | 1.65 | null | Palliative (P) | null | 2014-04-16 | BENDAMUSTINE + RITUXIMAB | N | N | 330012089 | BENDAMUSTINE + RITUXIMAB |
| 330003062 | 330001628 | 1.66 | 93.5 | null | 2016-09-23 | 2016-09-23 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330012091 | BENDAMUSTINE + RITUXIMAB |
| 330003063 | 330001629 | 1.76 | 75.8 | Palliative (P) | 2013-04-22 | 2013-05-07 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012092 | CARBOPLATIN + PACLITAXEL |
| 330003064 | 330001629 | null | 95 | Disease modification (D) | 2016-08-04 | 2016-09-21 | Carboplatin + Paclitaxel (weekly) | null | N | 330012092 | CARBOPLATIN + PACLITAXEL |
| 330003065 | 330001629 | 1.78 | 64.2 | Curative (C) | 2016-11-20 | 2016-12-08 | DOXORUBICIN | null | N | 330012092 | DOXORUBICIN |
| 330003066 | 330001629 | 1.66 | 102.6 | Palliative (P) | 2015-11-26 | 2015-11-28 | Doxorubicin 75mg/m2 | N | N | 330012092 | DOXORUBICIN |
| 330003067 | 330012148 | 1.64 | 67.4 | Adjuvant (A) | 2014-10-19 | 2014-10-24 | Bendamustine+Rituximab (1st Course) | N | N | 330012104 | BENDAMUSTINE + RITUXIMAB |
| 330003068 | 330012148 | 1.67 | 71 | Palliative (P) | 2013-04-18 | 2013-04-21 | Carboplatin + Etoposide iv&po | N | N | 330012104 | CARBOPLATIN + ETOPOSIDE |
| 330003069 | 330012148 | 1.72 | 50.2 | Disease modification (D) | 2015-04-01 | 2015-04-04 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330012104 | BENDAMUSTINE + RITUXIMAB |
| 330003070 | 330001630 | 1.66 | 66 | Curative (C) | 2013-09-13 | 2013-10-04 | BENDAMUSTINE + RITUXIMAB | N | N | 330012110 | BENDAMUSTINE + RITUXIMAB |
| 330003071 | 330001631 | 1.7 | 64.75 | Palliative (P) | 2015-08-31 | 2015-08-31 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330012114 | LIPOSOMAL DOXORUBICIN |
| 330003072 | 330001631 | 1.83 | 77 | Disease modification (D) | null | 2016-02-07 | Rituximab | N | N | 330012114 | RITUXIMAB |
| 330003073 | 330001632 | 1.71 | 93.4 | Palliative (P) | 2016-07-14 | 2016-07-14 | Carboplatin AUC 6 - 10 | 02 | N | 330012123 | CARBOPLATIN |
| 330003074 | 330001632 | 1.8 | 78 | Curative (C) | 2017-09-08 | 2017-09-08 | Carboplatin + Etoposide IV 3 day | N | N | 330012123 | CARBOPLATIN + ETOPOSIDE |
| 330003075 | 330001633 | 1.66 | 52 | Curative (C) | 2016-04-20 | 2016-04-22 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330012130 | LIPOSOMAL DOXORUBICIN |
| 330003076 | 330001634 | 1.7 | 63.15 | Disease modification (D) | 2015-09-13 | 2015-09-29 | BENDAMUSTINE + RITUXIMAB | N | N | 330012133 | BENDAMUSTINE + RITUXIMAB |
| 330003077 | 330001634 | 1.73 | 91 | 4 | 2014-05-24 | 2014-05-27 | Carboplatin + Paclitaxel (3 weekly) | null | null | 330012133 | CARBOPLATIN + PACLITAXEL |
| 330003078 | 330001635 | 1.7 | 102 | Palliative (P) | 2014-06-28 | 2014-07-05 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012135 | CARBOPLATIN + PACLITAXEL |
| 330003079 | 330001636 | 1.68 | 7.5 | Palliative (P) | 2016-11-20 | 2016-11-30 | BENDAMUSTINE + RITUXIMAB | N | N | 330012136 | BENDAMUSTINE + RITUXIMAB |
| 330003080 | 330006869 | 1.7 | 57.8 | Palliative (P) | 2014-08-14 | 2014-08-22 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012138 | CARBOPLATIN + PACLITAXEL |
| 330003081 | 330001637 | 1.8 | null | Disease modification (D) | 2016-01-10 | 2016-01-24 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330012139 | BENDAMUSTINE + RITUXIMAB |
| 330003082 | 330001638 | 1.79 | 75 | Palliative (P) | 2017-01-21 | 2017-01-25 | Liposomal Doxorubicin (20mg/m2) | 2 | N | 330012140 | LIPOSOMAL DOXORUBICIN |
| 330003083 | 330001638 | 1.9 | 91.9 | Curative (C) | null | 2016-03-26 | BENDAMUSTINE + RITUXIMAB | N | N | 330012140 | BENDAMUSTINE + RITUXIMAB |
| 330003084 | 330001638 | 1.73 | 62.6 | Disease modification (D) | 2016-05-31 | 2016-08-13 | BENDAMUSTINE + RITUXIMAB | N | N | 330012140 | BENDAMUSTINE + RITUXIMAB |
| 330003085 | 330001638 | 1.85 | 104.8 | Palliative (P) | 2015-10-10 | 2015-10-10 | CARBOPLATIN | 02 | N | 330012140 | CARBOPLATIN |
| 330003086 | 330001638 | 1.85 | 44.5 | Adjuvant (A) | 2014-03-24 | 2014-03-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | 330012140 | CARBOPLATIN + PACLITAXEL |
| 330003087 | 330001638 | 1.66 | 72.2 | Disease modification (D) | null | 2016-01-26 | Rituximab | null | null | 330012140 | RITUXIMAB |